Rubicon Research IPO is to open on October 9, 2025. It is a Mainboard IPO that will raise ₹1,377.50 crores. The Rubicon Research IPO price band is fixed at ₹461 to ₹485 with a market lot of 30 Shares.
Rubicon Research IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain |
| 16 Oct | ₹145 |  | 29.89% |
| 15 Oct | ₹120 | | 24.74% |
| 14 Oct | ₹118 | | 24.32% |
| 13 Oct | ₹96 |  | 19.79% |
| 11 Oct | ₹110 | | 22.68% |
| 10 Oct | ₹100 | | 20.61% |
| 9 Oct | ₹94 | | 19.38% |
| 8 Oct | ₹80 | | 16.49% |
| 7 Oct | ₹80 | | 16.49% |
| 6 Oct | ₹68 | | 14.02% |
Rubicon Research IPO Details
| IPO Open Date | October 9, 2025 |
| IPO Close Date | October 13, 2025 |
| Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹461 to ₹485 Per Share |
| Issue Size | Approx ₹1,377.50 Crores |
| Fresh Issue | Approx ₹500 Crores |
| Offer for Sale: | Approx 1,80,92,762 Equity Shares |
| Issue Type | Book Built Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Rubicon Research IPO Dates
| IPO Open Date: | October 9, 2025 |
| IPO Close Date: | October 13, 2025 |
| Basis of Allotment: | October 14, 2025 |
| Refunds: | October 15, 2025 |
| Credit to Demat Account: | October 15, 2025 |
| IPO Listing Date: | October 16, 2025 |
| IPO Bidding Cut-off Time: | October 13, 2025 – 5 PM |
Business Overview
Rubicon Research is one of the leading pharmaceutical formulations companies and focuses on innovation through dedicated research and development. Moreover, their portfolio includes specialty products and drug-device combination products, aimed mainly at regulated markets, especially the United States.
Furthermore, they believe their multi-disciplinary, data-driven, and return on investment (“ROI”) centric product selection framework is geared towards identifying sustainable opportunities for new product development. Moreover, they find and go after opportunities that give an edge by using skills in development, manufacturing, and sales to grow market share.
The company has unique strengths, the Fastest-growing Indian pharmaceutical company compared to peers, a Data-driven way to choose products, a Strong research and development team, Solid sales and distribution network in the US.
Rubicon Research IPO GMP aka Grey Market Premium FAQs:
What is Rubicon Research IPO GMP Today?
What is Rubicon Research IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Rubicon Research IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
